16-19078240-C-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_016138.5(COQ7):c.*82C>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.181 in 1,017,492 control chromosomes in the GnomAD database, including 17,818 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.18 ( 2510 hom., cov: 31)
Exomes 𝑓: 0.18 ( 15308 hom. )
Consequence
COQ7
NM_016138.5 3_prime_UTR
NM_016138.5 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.40
Publications
10 publications found
Genes affected
COQ7 (HGNC:2244): (coenzyme Q7, hydroxylase) The protein encoded by this gene is similar to a mitochondrial di-iron containing hydroxylase in Saccharomyces cerevisiae that is involved with ubiquinone biosynthesis. Mutations in the yeast gene lead to slower development and longer life span. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2010]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 16-19078240-C-G is Benign according to our data. Variant chr16-19078240-C-G is described in ClinVar as Benign. ClinVar VariationId is 1288927.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.208 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.179 AC: 27055AN: 150770Hom.: 2511 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
27055
AN:
150770
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.181 AC: 157092AN: 866648Hom.: 15308 Cov.: 11 AF XY: 0.178 AC XY: 79227AN XY: 444728 show subpopulations
GnomAD4 exome
AF:
AC:
157092
AN:
866648
Hom.:
Cov.:
11
AF XY:
AC XY:
79227
AN XY:
444728
show subpopulations
African (AFR)
AF:
AC:
2644
AN:
18592
American (AMR)
AF:
AC:
5444
AN:
24156
Ashkenazi Jewish (ASJ)
AF:
AC:
3394
AN:
18460
East Asian (EAS)
AF:
AC:
4724
AN:
31950
South Asian (SAS)
AF:
AC:
5399
AN:
57262
European-Finnish (FIN)
AF:
AC:
10014
AN:
47012
Middle Eastern (MID)
AF:
AC:
530
AN:
4320
European-Non Finnish (NFE)
AF:
AC:
118093
AN:
625886
Other (OTH)
AF:
AC:
6850
AN:
39010
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
6042
12083
18125
24166
30208
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
3340
6680
10020
13360
16700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.179 AC: 27057AN: 150844Hom.: 2510 Cov.: 31 AF XY: 0.180 AC XY: 13240AN XY: 73618 show subpopulations
GnomAD4 genome
AF:
AC:
27057
AN:
150844
Hom.:
Cov.:
31
AF XY:
AC XY:
13240
AN XY:
73618
show subpopulations
African (AFR)
AF:
AC:
5996
AN:
41178
American (AMR)
AF:
AC:
3244
AN:
15174
Ashkenazi Jewish (ASJ)
AF:
AC:
607
AN:
3464
East Asian (EAS)
AF:
AC:
763
AN:
5142
South Asian (SAS)
AF:
AC:
413
AN:
4764
European-Finnish (FIN)
AF:
AC:
2162
AN:
10084
Middle Eastern (MID)
AF:
AC:
60
AN:
290
European-Non Finnish (NFE)
AF:
AC:
13110
AN:
67752
Other (OTH)
AF:
AC:
372
AN:
2086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1135
2269
3404
4538
5673
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
292
584
876
1168
1460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
343
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.